Solstein Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Hold |
1,036
| – | – | 0.06% | 144 |
|
|
2025
Q1 | $116K | Hold |
1,036
| – | – | 0.07% | 123 |
|
|
2024
Q4 | $95.7K | Hold |
1,036
| – | – | 0.05% | 131 |
|
|
2024
Q3 | $86.9K | Hold |
1,036
| – | – | 0.05% | 137 |
|
|
2024
Q2 | $71.1K | Hold |
1,036
| – | – | 0.05% | 135 |
|
|
2024
Q1 | $75.9K | Hold |
1,036
| – | – | 0.05% | 125 |
|
|
2023
Q4 | $83.9K | Hold |
1,036
| – | – | 0.06% | 126 |
|
|
2023
Q3 | $77.6K | Hold |
1,036
| – | – | 0.07% | 128 |
|
|
2023
Q2 | $79.8K | Hold |
1,036
| – | – | 0.07% | 129 |
|
|
2023
Q1 | $86K | Hold |
1,036
| – | – | 0.07% | 123 |
|
|
2022
Q4 | $88.9K | Hold |
1,036
| – | – | 0.07% | 134 |
|
|
2022
Q3 | $64K | Hold |
1,036
| – | – | 0.06% | 142 |
|
|
2022
Q2 | $64K | Hold |
1,036
| – | – | 0.05% | 162 |
|
|
2022
Q1 | $62K | Hold |
1,036
| – | – | 0.04% | 177 |
|
|
2021
Q4 | $75K | Hold |
1,036
| – | – | 0.05% | 183 |
|
|
2021
Q3 | $72K | Hold |
1,036
| – | – | 0.04% | 202 |
|
|
2021
Q2 | $71K | Hold |
1,036
| – | – | 0.09% | 194 |
|
|
2021
Q1 | $67K | Buy |
+1,036
| New | +$67K | 0.09% | 189 |
|
|
2020
Q4 | – | Sell |
-1,036
| Closed | -$65K | – | 134 |
|
|
2020
Q3 | $65K | Hold |
1,036
| – | – | 0.15% | 117 |
|
|
2020
Q2 | $80K | Hold |
1,036
| – | – | 0.19% | 90 |
|
|
2020
Q1 | $77K | Buy |
1,036
+480
| +86% | +$35.7K | 0.3% | 57 |
|
|
2019
Q4 | $36K | Buy |
+556
| New | +$36K | 0.07% | 128 |
|